Evidence map›Paper›PMID 30622376›Full record

ArticleWorld journal of gastroenterology2018

Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine.

Domagoj Drmic, Mariam Samara, Tinka Vidovic, Dominik Malekinusic, Marko Antunovic, Borna Vrdoljak, Jelena Ruzman, Marija Milkovic Perisa, Katarina Horvat Pavlov, Jerusha Jeyakumar and 2 more

Open access · greenAbstract read
In one paragraph

Article in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Domagoj DrmicDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Mariam SamaraDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Tinka VidovicDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Dominik MalekinusicDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Marko AntunovicDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Borna VrdoljakDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Jelena RuzmanDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Marija Milkovic PerisaDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Katarina Horvat PavlovDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Jerusha JeyakumarDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Sven SeiwerthDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia.
Predrag SikiricDepartments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia. sikiric@mef.hr.
University of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo study the counteraction of perforated cecum lesion using BPC 157 and nitric oxide (NO) system agents.

methodsAlongside with the agents' application (after 1 min, medication (/kg, 10 mL/2 min bath/rat) includes: BPC 157 (10 μg), L-NAME (5 mg), L-arginine (100mg) alone or combined, and saline baths (controls)) on the rat perforate cecum injury, we continuously assessed the gross reappearance of the vessels (USB microcamera) quickly propagating toward the defect at the cecum surface, defect contraction, bleeding attenuation, MDA- and NO-levels in cecum tissue at 15 min, and severity of cecum lesions and adhesions at 1 and 7 d.

resultsPost-injury, during/after a saline bath, the number of vessels was significantly reduced, the defect was slightly narrowed, bleeding was significant and MDA-levels increased and NO-levels decreased. BPC 157 bath: the vessel presentation was markedly increased, the defect was noticeably narrowed, the bleeding time was shortened and MDA- and NO-levels remained normal. L-NAME: reduced vessel presentation but not more than the control, did not change defect and shortened bleeding. L-arginine: exhibited less vessel reduction, did not change the defect and prolonged bleeding. In combination, mutual counteraction occurred (L-NAME + L-arginine) or the presentation was similar to that of BPC 157 rats (BPC 157 + L-NAME; BPC 157 + L-arginine; BPC 157 + L-NAME + L-arginine), except the defect did not change. Thereby at day 1 and 7, saline, L-NAME, L-arginine and L-NAME + L-arginine failed (defect was still open and large adhesions present).

conclusionThe therapeutic effect was achieved with BPC 157 alone or in combination with L-NAME and L-arginine as it was able to consolidate the stimulating and inhibiting effects of the NO-system towards more effective healing recruiting vessels.

Indexed as

AnimalsAnti-Ulcer AgentsArginineCecumDisease Models, AnimalDrug Therapy, CombinationHumansIntestinal PerforationMaleNG-Nitroarginine Methyl EsterNitric OxidePeptide FragmentsProteinsRatsRats, WistarTreatment OutcomeAnti-Ulcer AgentsArginineBPC 157NG-Nitroarginine Methyl EsterNitric OxidePeptide FragmentsProteinsBPC 157L-arginineL-NAMEPerforated cecumRatsVessels

Identifiers

PMID30622376
PMCPMC6319139
OpenAlexW2907173452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.